Abstract
The small molecule nitric oxide (NO) plays important roles in many vital physiological and pathophysiological processes, including the modulation of cardiovascular processes, and key functions in the immune, nervous e respiratory systems. Several pathological conditions, such as sexual dysfunction and hypertension, are associated with deficiencies in the NO production or its inactivation. Due to the relative instability of NO in biological system, there is an increasing interest in the preparation of NO carriers as an efficient platform to carry and deliver therapeutic and relevant amounts of NO in biomedical applications. Among these approaches, NO-releasing nanomaterials have been described as promising strategy that could promote the spatio-temporal production of NO, in several pharmacological applications. The scope of this review is to point out the recent advances in the synthesis of versatile NO-releasing nanomaterials based on several materials, including polymeric nanoparticles, dendrimers, liposomes, solid lipid nanoparticles, metallic nanoparticles, silica nanoparticles, and carbon nanotubes. Although important progress in this area, some drawbacks still need to be overcome in order to translate these research innovations into practical applications. In this scenario, this review describes the state of the art of versatile nanostructured NO donors and their biomedical applications.
Keywords: Drug Release, Nanomedicine, Nanostructured Materials, Nitric Oxide, Nitric Oxide Donors, Polymeric Nanoparticles.
Mini-Reviews in Medicinal Chemistry
Title:Nanoparticulated Nitric Oxide Donors and their Biomedical Applications
Volume: 17 Issue: 3
Author(s): Amedea B. Seabra and Nelson Duran
Affiliation:
Keywords: Drug Release, Nanomedicine, Nanostructured Materials, Nitric Oxide, Nitric Oxide Donors, Polymeric Nanoparticles.
Abstract: The small molecule nitric oxide (NO) plays important roles in many vital physiological and pathophysiological processes, including the modulation of cardiovascular processes, and key functions in the immune, nervous e respiratory systems. Several pathological conditions, such as sexual dysfunction and hypertension, are associated with deficiencies in the NO production or its inactivation. Due to the relative instability of NO in biological system, there is an increasing interest in the preparation of NO carriers as an efficient platform to carry and deliver therapeutic and relevant amounts of NO in biomedical applications. Among these approaches, NO-releasing nanomaterials have been described as promising strategy that could promote the spatio-temporal production of NO, in several pharmacological applications. The scope of this review is to point out the recent advances in the synthesis of versatile NO-releasing nanomaterials based on several materials, including polymeric nanoparticles, dendrimers, liposomes, solid lipid nanoparticles, metallic nanoparticles, silica nanoparticles, and carbon nanotubes. Although important progress in this area, some drawbacks still need to be overcome in order to translate these research innovations into practical applications. In this scenario, this review describes the state of the art of versatile nanostructured NO donors and their biomedical applications.
Export Options
About this article
Cite this article as:
Seabra B. Amedea and Duran Nelson, Nanoparticulated Nitric Oxide Donors and their Biomedical Applications, Mini-Reviews in Medicinal Chemistry 2017; 17 (3) . https://dx.doi.org/10.2174/1389557516666160808124624
DOI https://dx.doi.org/10.2174/1389557516666160808124624 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs
Current Molecular Pharmacology Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Current Drug Metabolism New Lipid Modulating Drugs: The Role of Microsomal Transport Protein Inhibitors
Current Pharmaceutical Design Personalized and Participatory Medicine as a Future Tool to Combat Cardiovascular Disease in Developing Countries
Current Pharmacogenomics and Personalized Medicine Pharmacokinetics of Topical Ocular Drug Delivery: Potential Uses for the Treatment of Diseases of the Posterior Segment and Beyond
Current Drug Metabolism Development and Validation of Novel UPLC-MS/MS Method for the Analysis of Macitentan in Pharmaceutical Formulations
Current Pharmaceutical Analysis Insulin Therapy in Pregnancy Hypertensive Diseases and its Effect on the Offspring and Mother Later in Life
Current Vascular Pharmacology When Nutraceuticals Reinforce Drugs Side Effects: A Case Report
Current Drug Safety The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Ultrasonic-Promoted One-Pot Synthesis of 4H-chromenes, pyrano[2,3- d]pyrimidines, and 4H-pyrano[2,3-c]pyrazoles
Letters in Organic Chemistry Sex Impact on Biomarkers, Pharmacokinetics and Pharmacodynamics
Current Medicinal Chemistry Editorial [ Cardiovascular Risk Factor Modification: A sine qua non in the Management of Vascular Surgery Patients ]
Current Vascular Pharmacology Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone System
Current Pharmaceutical Design Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
Current Drug Therapy Editorial (Thematic Issue: Interventional Management of Hypertension and Cardiovascular Disease: The Beginning of a New Era?)
Current Vascular Pharmacology New Pathways for Reactive Oxygen Species Generation in Inflammation and Potential Novel Pharmacological Targets
Current Pharmaceutical Design Chronopharmaceutics Based Modern Colon Specific Drug Delivery Systems
Current Drug Discovery Technologies Expression, Purification and Characterization of Recombinant Canine FGF21 in Escherichia coli
Protein & Peptide Letters Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology